News NICE recommends Bayer drug for severe short-sightedness Eylea should be funded in mCNV, says NICE
News Bayer gains first Aliqopa approval in follicular lymphoma Bayer has gained FDA accelerated approval for its follicular lymphoma drug Aliqopa (copanlisib), giving it entry to the haemato-oncology market for the first time.
News Bayer unveils latest funding for digital health start-ups Startups focus on medical adherence, endometriosis, atrial fibrillation, and deep vein thrombosis.
News EUSA Pharma's Fotivda approved in EU for kidney cancer UK pharma gets licence for second cancer drug
News NICE close to clearing Cancer Drugs Fund backlog Only five drugs left to assess from old scheme.
News Daiichi Sankyo anticoagulant gains EU label boost Label gives guidance in use when restoring normal heart rhythm
Oncology CAR-T therapies: Faster, better, cheaper In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Phil Johnson, MD, president and CEO of Interius Biotherapeutics.
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
